Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck
Main Authors: | Iberri, David J., Colevas, A. Dimitrios |
---|---|
Format: | Online |
Language: | English |
Published: |
AlphaMed Press
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786348/ |
Similar Items
-
The Use of Epidermal Growth Factor Receptor Monoclonal Antibodies in Squamous Cell Carcinoma of the Head and Neck
by: Russell, Jeffery S., et al.
Published: (2012) -
Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor
by: Singh, Tripti, et al.
Published: (2015) -
Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts.
by: Stanton, P., et al.
Published: (1994) -
Human epidermal growth factor receptor-2 expression in head and neck squamous cell carcinoma: A potential for targeted therapy?
by: Ravi C Nayar, et al.
Published: (2016-01-01) -
Antiepidermal Growth Factor Receptor Therapy in Squamous Cell Carcinoma of the Head and Neck
by: Shaib, Walid, et al.
Published: (2012)